Treatment Outcomes
Importance of Prompt Treatment for Neuroleptic Malignant Syndrome
Receiving timely medical care is crucial in the treatment of neuroleptic malignant syndrome (NMS) to avoid complications, prolonged recovery, or even fatality. Fortunately, immediate and intensive treatment can greatly diminish these risks. If an individual is diagnosed and treated within 14 days of symptom development, a complete recovery with no lasting effects is typically expected. While it is not uncommon for NMS to recur, healthcare professionals and patients can significantly reduce the likelihood of recurrence by delaying the re-administration of neuroleptic drugs for a minimum of two weeks after the episode. This simple precaution decreases the chances of recurrence from 60% to 30%.
Advancements in Medicine for Neuroleptic Malignant Syndrome
Over the years, there have been significant advancements in the medical field regarding the prevention and treatment of neuroleptic malignant syndrome (NMS). Since its initial identification in the 1950s, increased awareness, dedicated research, and the development of new neuroleptics have contributed to a decline in the prevalence of this condition. In fact, the occurrence of NMS has reduced from 3.2% to a mere 0.02% over the past five decades. Moreover, the mortality rate associated with NMS has also shown a positive trend, decreasing from 30% to just 10%.